Fox Chase Cancer Center-Rockledge is a clinical research site located in Rockledge, Pennsylvania, United States 19046.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Fox Chase Cancer Center-Rockledge has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Non-muscle-invasive Bladder Cancer, Recurrent Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8.
Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Fox Chase Cancer Center-Rockledge has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Fox Chase Cancer Center-Rockledge has 2 clinical trials on record, with 2 currently active. Their work covers Non-muscle-invasive Bladder Cancer, Recurrent Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8.
Fox Chase Cancer Center-Rockledge has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.